Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $84.92 USD
Change Today -0.08 / -0.09%
Volume 1.4M
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carol A. Ammon M.B.A.

AgeTotal Calculated CompensationThis person is connected to 56 board members in 2 different organizations across 3 different industries.

See Board Relationships
62--

Background*

Ms. Carol A. Ammon, MBA serves as the Chief Executive Officer of Endo Pharmaceuticals, Inc. Ms. Ammon founded Endo Pharmaceuticals Solutions Inc. She also founded and served as the Chairman and Chief Executive Officer of Endo Pharmaceuticals Holdings Inc., from February 2002 to May 20, 2005 and its President from February 2002 to April 2003. Prior to joining Endo in August 1997, Ms. Ammon served as the President of DuPont Mercks U.S. Pharmaceuticals Division from 1996 ...

Read Full Background

Corporate Headquarters*

Minerva House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 268 2000
Fax: --

Board Members Memberships*

Founder
Founder
Vice Chairman
Trustee
Former Chairperson
2005-2008
Former Director, Chairman of Compensation Committee, Member of Corporate Governance Committee and Member of Strategic Planning Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $84.92 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
$900.0K
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt public limited company
$905.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO INTERNATIONAL PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.